Companies / Takeda Pharmaceutical Co Ltd

Takeda Pharmaceutical Co Ltd

NYSE: TAKForeign · IFRSCIK 1395064TOKYO

Financials · FY2025 · JPY

Revenue¥4.58T
Net income¥108.14B
Total debt
Cash¥385.11B
Diluted EPS¥67.23
Shares outstanding1.56B

Ownership

1.56B shares outstanding
5.7%Institutions
Ownership
Institutions5.69%88,618,849
Public float94.31%1,469,146,747

% of common shares outstanding (single-class filing figure). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 28

View all →
Insider% of sharesShares
Bitetti Teresa MariePresident, OBU
Clark Ian TDirector
Duprey Lauren RusckowskiChief Transformation Officer
Farajallah Awny Samaan BotrosChief Medical Officer
Furney Natalie Anne MarieGlobal General Counsel
Furuta MilanoChief Financial Officer · Director
Greenway Nicola Deidre PetalChief Human Resources Officer

Institutional holders 359

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Apr 27, 2026Weber Christophe Pierre
CEO
GrantAmerican Depositary Shares$0+165K
+65.25%
418,803
0.03% of shares
low
Apr 27, 2026Weber Christophe Pierre
CEO
GrantOrdinary Shares$0+79K
+8.44%
1,014,200
0.07% of shares
low
Apr 27, 2026Furuta Milano
Executive
GrantOrdinary Shares$0+8K
+15.57%
57,900
<0.01% of shares
low
Apr 27, 2026Plump Andrew Stewart
Executive
GrantAmerican Depositary Shares$0+212K
+35.76%
806,572
0.05% of shares
low
Apr 27, 2026Ricci Gabriele
Executive
GrantAmerican Depositary Shares$0+35K
+28.19%
159,126
0.01% of shares
low
Apr 27, 2026Bitetti Teresa Marie
Executive
GrantAmerican Depositary Shares$0+65K
+33.65%
258,136
0.02% of shares
low
Apr 27, 2026Duprey Lauren Rusckowski
Executive
GrantAmerican Depositary Shares$0+60K
+35.60%
228,503
0.01% of shares
low
Apr 27, 2026Kim Julie So-Young
CEO
GrantAmerican Depositary Shares$0+105K
+32.46%
430,145
0.03% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
TAKADREquity874060205BBG000LF8708